Abstract
The burden of mental disorders represents huge costs to society and is deleterious to economic growth. Happiness and well-being have been acknowledged as a proxy for economic growth and nation development. In this regard, mental disorders are the leading factor hindering well-being and happiness. International organizations and global policies have been warned of the need to include mental health as a priority in countries’ national agendas. For this purpose, mental health and well-being were included in the United Nations Sustainable Goals for 2015–2030. Indirect costs of mental disorders are related to poverty, unemployment, productivity losses, low educational level, social exclusion and inequality, gender inequity, and violence. Depression and anxiety, schizophrenia, and mood disorders are the most burdensome mental disorders. Targeting the reduction of burden and indirect costs of mental disorders involves increasing investments in mental health and the efficiency of community mental healthcare, and also implementing cost-effective interventions. Economic evaluation should take into account broader outcomes and the indirect costs of mental disorders, because the effects of mental interventions also rely on social outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Read D. Utility theory from Jeremy Bentham to Daniel Kahneman. Working paper No: LSEOR 04–64. London: London School of Economics and Political Science; 2004. 28 Jan 2016.
Heliwell J, Layard R, Sachs J. The world happiness report. New York: Sustainable Development Solutions Network; 2013.
OECD. OECD guidelines on measuring subjective wellbeing. Paris: OECD Publishing; 2013.
Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Global priorities for addressing the Burden of mental, neurological, and substance use disorders. In: Patel, V et al (eds). Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).Washington (DC): The International Bank for Reconstruction and Development / The World Bank, DOI:10.1596/978-1-4648-0426-7_ch1 2016.
Thornicroft G, Deb T, Henderson C. Community mental health care worldwide: current status and further developments. World Psychiatry. 2016;15(3):276–86.
Trautmann S, Rehm J, Wittchen HU. The economic costs of mental disorders: do our societies react appropriately to the burden of mental disorders? EMBO Rep. 2016;17(9):1245–9.
Whiteford HA, Ferrari AJ, Degenhardt L, Feigin V, Vos T. The global burden of mental, neurological and substance use disorders: an analysis from the global burden of disease study 2010. PLoS One. 2015;10(2):e0116820.
OECD. Making mental health count:the social and economic costs of neglecting mental health care. OECD Health Policies Studies, OECD Publishing; Paris, 2014.
World Health Organization. The World Health Report 2001 Mental health: new understanding, new hope. World Health Organization: Geneve; 2001.
Thornicroft G, Votruba N. Does the United Nations care about mental health? Lancet Psychiatry. 2016;3(7):599–600.
Eaton J, McCay L, Semrau M, Chatterjee S, Baingana F, Araya R, et al. Scale up of services for mental health in low-income and middle-income countries. Lancet. 2011;378(9802):1592–603.
Levin C, Chisholm D. Cost-effectiveness and affordability of interventions, policies, and platforms for the prevention and treatment of mental, neurological, and substance use disorders. Mental, neurological, and substance use disorders: disease control priorities, 3rd ed. Volume 4 [Internet]. The International Bank for Reconstruction and Development/The World Bank; 2016 [Cited 14 Nov 2016]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27227237. In: Patel V, Chisholm D, ua T, editors. Mental, neurological, and substance use disorders: disease control priorities, Third Edition volume 4.Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2016. p. 219–36.
Chong HY, Teoh SL, Wu DB, Kotirum S, Chiou CF, Chaiyakunapruk N. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016;12:357–73.
WHO. The European observatory on health systems and policies. Health systems, health, wealth and societal well-being assessing the case for investing in health systems. Open University Press; Glasgow, 2015.
World Health Organization. Making choices in health: the WHO guide to cost-effectiveness analysis. WHO Publications. World Health Organization; Geneva, 2003.
Weehuizen R. Mental capital: the economic significance of mental health. University of Maastrich; Maastrich, 2008.
Knapp M, McDaid D, Parsonage M. Mental health promotion and mental illness prevention: the economic case. London: Department of Health, London; 2011.
Wong E, ollins R, Erully J. Reviewing the evidence base for mental health first aid. 2015. www.rand.org/content/dam/rand/pubs/research_reports/RR900/…/RAND_RR972.pdf. Rand Corporation; 2015.
Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3(5):415–24.
World Health Organization, Calouste Gulbenkian Foundation. Social determinants of mental health. Geneva: World Health Organization; 2014.
Razzouk D. Why should Brazil give priority to depression treatment in health resource allocation? Epidemiologia e Serviços de Saude. 2016;25(4):845–8.
United Nations. Transforming our world: the 2030 Agenda for sustainable development. United Nations; 2015. Report No: A/RES/70/1.
Knapp M. Hidden costs of mental illness. Br J Psychiatry. 2003;183:477–8.
Knapp M, Ilson S. Economic aspects of depression and its treatment. Curr Opin Psychiatry. 2002;15:69–75.
Mihalopoulos C, Chatterton ML. Economic evaluations of interventions designed to prevent mental disorders: a systematic review. Early Interv Psychiatry. 2015;9:85–92.
Bloom D, Cafiero E, Jane-Llopis E, Abrahams-Gessel S, Fathima S. The global economic Burden of Non-communicable disease. World Economic Forum; Geneva, 2011.
McGorry P. Prevention, innovation and implementation science in mental health: the next wave of reform. Br J Psychiatry Suppl. 2013;54:s3–4.
Lund C, Myer L, Stein DJ, Williams DR, Flisher AJ. Mental illness and lost income among adult south Africans. Soc Psychiatry Psychiatr Epidemiol. 2013;48(5):845–51.
Krol M, Papenburg J, Koopmanschap M, Brouwer W. Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. PharmacoEconomics. 2011;29(7):601–19.
Patel V, Kleinman A. Poverty and common mental disorders in developing countries. Bull World Health Organ. 2003;81:609–15.
WHO. Mental health and development: targeting people with mental health conditions as a vulnerable group. Geneva: WHO; 2010.
Rosenheck R. Cost-effectiveness of services for mentally ill homeless people: the application of research to policy and practice. Am J Psychiatry. 2000;157(10):1563–70.
Bonin P, Fournier L, Lais R. Predictors of mental health service utilization by people using resources for homeless people in Canada. Psychiatr Serv. 2007;58(7):936–41.
Ettner S, ., Frank R, Essler R. The impact of psychiatric disorders on labour market outcomes. Ind Labor Relat Rev 1997;51:64–81.
Marcotte D, Wilcox-Gok V. Estimating earnings losses due to mental illness: a quantile regression approach. J Ment Health Policy Econ. 2003;6:123–34.
Kessler RC, Heeringa S, Lakoma MD, Petukhova M, Rupp AE, Schoenbaum M, et al. Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication. Am J Psychiatry. 2008;165(6):703–11.
Dewa CS, McDaid D, Ettner SL. An international perspective on worker mental health problems: who bears the burden and how are costs addressed? Can J Psychiatr. 2007;52(6):346–56.
Marwaha S, Johnson S. Schizophrenia and employment – a review. Soc Psychiatry Psychiatr Epidemiol. 2004;39(5):337–49.
Thornicroft G, Tansella M, Becker T, Knapp M, Leese M, Schene A, et al. The personal impact of schizophrenia in Europe. Schizophr Res. 2004;69(2–3):125–32.
Waghorn G, Chant D, Jaeger J. Employment functioning and disability among community residents with bipolar affective disorder: results from an Australian community survey. Bipolar Disord. 2007;9(1–2):166–82.
Strejilevich S, Correa E. Cost and challenges of bipolar disorders: focus in South America region. J Affect Disord 2007;98:165–167.
Jenkins R, Bhugra D, Bebbington P, Brugha T, Farrell M, Coid J, et al. Debt, income and mental disorder in the general population. Psychol Med. 2008;38(10):1485–93.
Whooley MA, Kiefe CI, Chesney MA, Markovitz JH, Matthews K, Hulley SB. Depressive symptoms, unemployment, and loss of income: the CARDIA study. Arch Intern Med. 2002;162(22):2614–20.
Tarricone R, Gerzeli S, Montanelli R, Frattura L, Percudani M, Racagni G. Direct and indirect costs of schizophrenia in community psychiatric services in Italy. The GISIES study. Interdisciplinary study group on the economic impact of schizophrenia. Health Policy. 2000;51(1):1–18.
Allegri RF, Butman J, Arizaga R, Machnicki G, Serrano C, Taragano F, et al. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina. Int Psychogeriatr. 2007;19(4):705–18.
Dias A, Samuel R, Patel V, Prince M, Parameshwaran R, Krishnamoorthy ES. The impact associated with caring for a person with dementia: a report from the 10/66 dementia research Group’s Indian network. Int J Geriatr Psychiatry. 2004;19(2):182–4.
Cavallo MC, Fattore G. The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Dis Assoc Disord. 1997;11(4):184–90.
Barroso SM, Bandeira M, Nascimento E. Sobrecarga de familiares de pacientes psiquiátricos atendidos na rede pública. [burden in family caregivers of psychiatric patients attending public services]. Rev psiquiatr clín. 2007;34(6):270–7.
Schofield DJ, Shrestha RN, Percival R, Passey ME, Callander EJ, Kelly SJ. The personal and national costs of mental health conditions: impacts on income, taxes, government support payments due to lost labour force participation. BMC Psychiatry. 2011;11:72.
Chisholm D, Diehr P, Knapp M, Patrick D, Treglia M, Simon G. Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO). Br J Psychiatry. 2003;183:121–31.
Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135–44.
Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet. 2007;370(9590):841–50.
Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Berglund PA, Corey-Leslie P. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465–75.
Adler DA, McLaughlin TJ, Rogers WH, Chang H, Lapitsky L, Lerner D. Job performance deficits due to depression. Am J Psychiatry. 2006;163(9):1569–76.
Muralli V, Oyebode F. Poverty, social inequality and mental health. Adv Psychiatr Treat. 2004;10:216–24.
Amaddeo F, Jones J. What is the impact of socio-economic inequalities on the use of mental health services? Epidemiol Psichiatr Soc. 2007;16(1):16–9.
Thornicroft G, Rose D, Mehta N. Discrimination against people with mental illness: what can psychiatrists do?†. Adv Psychiatr Treat. 2010;16:53–9.
Wahlbeck K, McDaid D. Actions to alleviate the mental health impact of the economic crisis. World Psychiatry. 2012;11(3):139–45.
Meltzer H, Corbin T, Gatward R, Goodman R. Persistence, onset, risk factors and outcomes of childhood mental disorders. Available: http://www.nationalstatistics.org.uk/downloads/theme_health/PMA-ChildPersist.pdf. London: Division of the Office for National Statistics; 2003.
Fuller R, Nopoulos P, Arndt S, O’Leary D, Ho BC, Andreasen NC. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry. 2002;159(7):1183–9.
Cannon M, Jones P, Huttunen MO, Tanskanen A, Huttunen T, Rabe-Hesketh S, et al. School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch Gen Psychiatry. 1999;56(5):457–63.
Hollis C. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiatry. 2000;157(10):1652–9.
Hanssens L, LItalian G, Pugner K. Assessment of sociodemographic characteristics including employment, income and usual residence of European patients with schizophrenia: results from the star study. Eur Psychiatry. 2007;22(suppl):S101–220.
Jarbin H, Ott Y, von Knorring AL. Adult outcome of social function in adolescent-onset schizophrenia and affective psychosis. J Am Acad Child Adolesc Psychiatry. 2003;42(2):176–83.
Bolis M, PAHO/WHO. The impact of the caracas declaration on the modernization of mental health legislation in Latin America and the English-speaking Caribbean. 2002 Jul 9. Amsterdam: PAHO/WHO; 2002 p. 1–19.
Thornicroft G, Alem A, Antunes Dos Santos R, Barley E, Drake RE, Gregorio G, et al. WPA guidance on steps, obstacles and mistakes to avoid in the implementation of community mental health care. World Psychiatry. 2010;9(2):67–77.
Bonney S, Stickley T. Recovery and mental health: a review of the British literature. J Psychiatr Ment Health Nurs. 2008;15(2):140–53.
Cesur R, Sabia J, Tekin E. The psychological costs of war: military combat and mental health. J Health Econ. 2013;32(1):51–65.
World Health Organization, United Nations High Commissioner. mhGAP humanitarian intervention guide (mhGAP-HIG): clinical management of mental, neurological and substance use conditions in humanitarian emergencies. Geneva: WHO; 2015.
Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from disease control priorities, 3rd edition. Lancet. 2016;387(10028):1672–85.
Chisholm D, Flisher AJ, Lund C, Patel V, Saxena S, Thornicroft G, et al. Scale up services for mental disorders: a call for action. Lancet. 2007;370(9594):1241–52.
Chisholm D. Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health Organization. World Psychiatry. 2005;4(1):37–44.
Chisholm D, Doran C, Shibuya K, Rehm J. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev. 2006;25(6):553–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Razzouk, D. (2017). Burden and Indirect Costs of Mental Disorders. In: Razzouk, D. (eds) Mental Health Economics. Springer, Cham. https://doi.org/10.1007/978-3-319-55266-8_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-55266-8_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55265-1
Online ISBN: 978-3-319-55266-8
eBook Packages: MedicineMedicine (R0)